Scarica l'app Stockscreener
9.10
1.79%
0.16
Dopo l'orario di chiusura:
9.10
Pharming Group N V Adr Borsa (PHAR) Ultime notizie
Pharming Group stock gains on KL1333’s blockbuster potential, says RBC - Investing.com India
Pharming announces public cash offer to the shareholders of Abliva AB - GlobeNewswire Inc.
H.C. Wainwright reiterates Buy on Pharming stock, pediatric trial shows safety and tolerability - Investing.com
Jefferies initiates Pharming Group shares with Buy on revenue growth - Investing.com India
Oppenheimer cuts Pharming Group stock target, Outperform on Q3 results - Investing.com India
Earnings call: Pharming Group NV reports growth amid CEO transition - Investing.com
Earnings call: Pharming Group NV sees robust growth in Q3, CEO to step down - Investing.com
October 2024's Promising Penny Stocks to Watch - Yahoo Finance
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance
Earnings call: Pharming Group reports robust growth and pipeline expansion - Investing.com India
Pharming Group stock hits 52-week low at $6.9 amid challenges - Investing.com
Bath & Body Works, Designer Brands And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains? - Yahoo Finance
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up - Nasdaq
Can Pharming Group N.V. Sponsored ADR (PHAR) Run Higher on Rising Earnings Estimates? - Zacks Investment Research
PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):